hydroxychloroquine has been researched along with Bowel Diseases, Inflammatory in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Excerpt | Relevance | Reference |
---|---|---|
"Dyspnea is associated with a more severe infection." | 1.62 | Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. ( Algaba, A; Bermejo, F; Bonillo, D; Garza, D; Guerra, I; Jiménez, L; Mar Aller, M; Molina Esteban, LM, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Winthrop, KL | 1 |
Brunton, AE | 1 |
Beekmann, S | 1 |
Polgreen, P | 1 |
Baddley, J | 1 |
Saag, KG | 1 |
Calabrese, C | 1 |
Calabrese, L | 1 |
Robinson, PC | 1 |
Wallace, ZS | 1 |
Curtis, JR | 1 |
Guerra, I | 1 |
Algaba, A | 1 |
Jiménez, L | 1 |
Mar Aller, M | 1 |
Garza, D | 1 |
Bonillo, D | 1 |
Molina Esteban, LM | 1 |
Bermejo, F | 1 |
Abid, H | 1 |
Atmani, I | 1 |
Lahmidani, N | 1 |
El Yousfi, M | 1 |
Benajah, DA | 1 |
Ibrahimi, SA | 1 |
El Abkari, M | 1 |
Cooper, WO | 1 |
Cheetham, TC | 1 |
Li, DK | 1 |
Stein, CM | 1 |
Callahan, ST | 1 |
Morgan, TM | 1 |
Shintani, AK | 1 |
Chen, N | 1 |
Griffin, MR | 1 |
Ray, WA | 1 |
Wu, YH | 1 |
Chang, JY | 1 |
Chen, HM | 1 |
Wang, YP | 1 |
Knight, AK | 1 |
Cunningham-Rundles, C | 1 |
Cotton, P | 1 |
1 review available for hydroxychloroquine and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Inflammatory and autoimmune complications of common variable immune deficiency.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2006 |
6 other studies available for hydroxychloroquine and Bowel Diseases, Inflammatory
Article | Year |
---|---|
SARS CoV-2 infection among patients using immunomodulatory therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized | 2021 |
Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain.
Topics: Adult; Biological Therapy; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Dyspnea; Fema | 2021 |
[Chronic inflammatory bowel diseases: what happens when SARS-CoV-2 occurs? Preliminary results from a study conducted at the Hassan II University Teaching Hospital in Fes, Morocco (a case report)].
Topics: Adult; Azithromycin; COVID-19; COVID-19 Drug Treatment; Female; Hospitals, University; Humans; Hydro | 2021 |
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.
Topics: Adult; Arthritis; Cohort Studies; Congenital Abnormalities; Female; Fetal Death; Follow-Up Studies; | 2014 |
Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease.
Topics: Adult; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inflammatory Bowel | 2015 |
New approaches may aid patients with inflammatory bowel disease.
Topics: Aminosalicylic Acids; Cyclosporins; Fish Oils; Humans; Hydroxychloroquine; Inflammatory Bowel Diseas | 1990 |